• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    40 Stocks Moving In Wednesday's Mid-Day Session

    2/9/22 12:11:19 PM ET
    $ABST
    $ADGI
    $AEG
    $APVO
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Life Insurance
    Finance
    Get the next $ABST alert in real time by email

    Gainers

    • US Ecology, Inc. (NASDAQ:ECOL) shares jumped 68.1% to $47.34 after Republic Services reported it will buy the company at $48 per share in cash.
    • Tritium DCFC Limited (NASDAQ:DCFC) gained 65.4% to $15.78. Tritium DCFC shares surged nearly 40% Tuesday after the Australian EV charging company announced its new manufacturing facility will be located in the United States. Tritium CEO Jane Hunter appeared at the White House to make the announcement yesterday.
    • Infobird Co., Ltd (NASDAQ:IFBD) gained 32.6% to $1.2393. Infobird recently signed a contract with subsidiary of Nippi Japan for digital marketing solutions.
    • Doximity, Inc. (NYSE:DOCS) shares gained 25.1% to $62.30 after the company reported better-than-expected Q3 results and issued FY22 sales guidance above estimates.
    • Aptevo Therapeutics Inc. (NASDAQ:APVO) jumped 20.5% to $7.29 after the company announced it has earned a $10 million non-dilutive milestone payment related to 2021 sales of RUXIENCE.
    • Absolute Software Corporation (NASDAQ:ABST) gained 17.9% to $9.47 after the company reported better-than-expected Q2 sales results and issued FY22 sales guidance. TD Securities upgraded Absolute Software from Hold to Buy and raised the price target from $11 to $13.
    • Adagio Therapeutics, Inc. (NASDAQ:ADGI) gained 16.7% to $11.45.
    • Gracell Biotechnologies Inc. (NASDAQ:GRCL) jumped 16.7% to $3.56.
    • Better Choice Company Inc. (NYSE:BTTR) gained 16% to $3.40.
    • Mersana Therapeutics, Inc. (NASDAQ:MRSN) gained 15.5% to $5.00. Mersana Therapeutics recently announced a research collaboration and license agreement with Janssen Biotech Inc, a unit of Johnson & Johnson, to discover antibody-drug conjugates (ADCs) for three targets.
    • GDS Holdings Limited (NASDAQ:GDS) gained 15.2% to $44.90. Morgan Stanley upgraded GDS Holdings from Equal-Weight to Overweight and announced a $60 price target.
    • Nu Holdings Ltd. (NYSE:NU) gained 14.6% to $10.20.
    • Sundial Growers Inc. (NASDAQ:SNDL) shares rose 13.7% to $0.5728 after the company announced that it has received an extension of 180 calendar days to regain compliance with Nasdaq's minimum bid price requirement.
    • Omnicom Group Inc. (NYSE:OMC) gained 13.3% to $89.44 after the company reported better-than-expected Q4 EPS and sales results.
    • Canopy Growth Corporation (NYSE:CGC) rose 12.8% to $8.68 after the company announced its fiscal third-quarter financial results.
    • NCR Corporation (NYSE:NCR) jumped 12.4% to $43.10 after the company reported better-than-expected Q4 adjusted EPS results.
    • Hub Group, Inc. (NASDAQ:HUBG) gained 10.6% to $83.71 after the company reported better-than-expected Q4 EPS and sales results. The company also issued FY22 EPS and sales guidance above analyst estimates.
    • Leafly Holdings, Inc. (NASDAQ:LFLY) rose 8.5% to $6.86 after dropping 11% on Tuesday.
    • ERYTECH Pharma S.A. (NASDAQ:ERYP) rose 8.1% to $2.0094. ERYTECH expanded its patent portfolio for the treatment of rare metabolic diseases.
    • Enphase Energy, Inc. (NASDAQ:ENPH) shares rose 7.8% to $155.71 after the company reported better-than-expected Q4 results and issued Q1 sales guidance above estimates.
    • Joby Aviation, Inc. (NYSE:JOBY) rose 7.6% to $5.01 after jumping 21% on Tuesday. Joby Aviation and SK Telecom recently announced partnership to introduce emissions-free aerial ridesharing services to cities and communities across South Korea.
    • Chipotle Mexican Grill, Inc. (NYSE:CMG) rose 7.5% to $1,569.51 as the company reported upbeat earnings for its fourth quarter. The company said it sees Q1 same-store sales up in mid to high single digits range.

    Also check out this: Executives Sell More Than $210M Of 5 Stocks

    Losers

    • Zosano Pharma Corporation (NASDAQ:ZSAN) shares dipped 50.4% to $0.2343 after the company reported pricing of $15.4 million public offering of common stock and warrants.
    • QuinStreet, Inc. (NASDAQ:QNST) shares fell 29% to $11.06 after the company reported worse-than-expected Q2 adjusted EPS and sales results and cut FY22 guidance. Lake Street downgraded QuinStreet from Buy to Hold.
    • New Relic, Inc. (NYSE:NEWR) fell 27.9% to $78.71 after the company reported worse-than-expected Q3 adjusted EPS results and issued Q4 and FY22 adjusted EPS guidance below estimates.
    • Society Pass Incorporated (NASDAQ:SOPA) shares fell 26.6% to $3.4369 after surging around 43% on Tuesday.
    • Avaya Holdings Corp. (NASDAQ:AVYA) dropped 22.1% to $13.89 after the company reported worse-than-expected Q1 adjusted EPS and sales results and issued Q2 and FY22 adjusted EPS guidance below estimates.
    • The Container Store Group, Inc. (NYSE:TCS) fell 19.6% to $8.46 after the company issued Q4 EPS guidance below estimates and said it expects a Q4 sales decline of approximately 11% year over year.
    • Cyren Ltd. (NASDAQ:CYRN) dropped 17.1% to $3.38. Cyren dropped 14% on Tuesday after the company announced a 1-for-20 reverse split.
    • American Rebel Holdings, Inc. (NASDAQ:AREB) declined 16.8% to $2.18. American Rebel gained around 19% on Tuesday following uplisting to Nasdaq on Monday.
    • Fast Radius, Inc. (NASDAQ:FSRD) fell 16.2% to $5.20.
    • Powell Industries, Inc. (NASDAQ:POWL) dropped 14.2% to $24.90 after the company posted a wider Q1 loss.
    • Adtalem Global Education Inc. (NYSE:ATGE) fell 13.8% to $24.78 after the company reported worse-than-expected Q2 adjusted EPS and sales results.
    • SES AI Corporation (NYSE:SES) dropped 13.8% to $5.24.
    • BioCardia, Inc. (NASDAQ:BCDA) shares fell 13.5% to $2.25 after jumping around 24% on Tuesday. BioCardia recently announced it received FDA Breakthrough Device Designation for CardiAMP cell therapy system for heart failure.
    • USANA Health Sciences, Inc. (NYSE:USNA) dropped 11.8% to $83.11 after the company reported worse-than-expected Q4 EPS and sales results.
    • Argo Group International Holdings, Ltd. (NYSE:ARGO) dipped 10.9% to $46.20. Argo Group said Q4 results will be negatively affected by adverse prior year reserve development and non-operating charges.
    • Cryo-Cell International, Inc. (NASDAQ:CCEL) dipped 9.4% to $8.16.
    • Aegon N.V. (NYSE:AEG) fell 7.9% to $5.71 following Q4 results.
    • Big Lots, Inc. (NYSE:BIG) shares fell 4.4% to $37.73. JP Morgan downgraded Big Lots from Neutral to Underweight and lowered the price target from $54 to $31.

    Also check out this: Executives Buy Around $64M Of 3 Stocks

    Get the next $ABST alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABST
    $ADGI
    $AEG
    $APVO

    CompanyDatePrice TargetRatingAnalyst
    Doximity Inc.
    $DOCS
    2/9/2026$34.00Hold → Buy
    Canaccord Genuity
    Hub Group Inc.
    $HUBG
    2/6/2026$27.00Buy → Sell
    Stifel
    Hub Group Inc.
    $HUBG
    2/6/2026$29.00Outperform → Neutral
    Robert W. Baird
    Doximity Inc.
    $DOCS
    2/6/2026$40.00Underweight → Neutral
    Analyst
    Enphase Energy Inc.
    $ENPH
    2/4/2026$52.00Hold → Buy
    HSBC Securities
    Enphase Energy Inc.
    $ENPH
    2/4/2026$41.00Underperform → Market Perform
    BMO Capital Markets
    Enphase Energy Inc.
    $ENPH
    2/4/2026$54.00Sector Perform → Outperform
    RBC Capital Mkts
    Enphase Energy Inc.
    $ENPH
    2/4/2026$35.00 → $40.00Hold
    TD Cowen
    More analyst ratings

    $ABST
    $ADGI
    $AEG
    $APVO
    SEC Filings

    View All

    Amendment: SEC Form S-1/A filed by Society Pass Incorporated

    S-1/A - SOCIETY PASS INCORPORATED. (0001817511) (Filer)

    2/6/26 5:26:07 PM ET
    $SOPA
    Real Estate

    Adtalem Global Education Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Covista Inc. (0000730464) (Filer)

    2/6/26 5:15:17 PM ET
    $ATGE
    Other Consumer Services
    Real Estate

    Society Pass Incorporated filed SEC Form 8-K: Other Events

    8-K - SOCIETY PASS INCORPORATED. (0001817511) (Filer)

    2/6/26 5:00:27 PM ET
    $SOPA
    Real Estate

    $ABST
    $ADGI
    $AEG
    $APVO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Greenridge Global: Sapience AI Investment Represents a Big Deal for Society Pass Incorporated (Nasdaq: SOPA) Shareholders

    NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Greenridge Global LLC ("Greenridge") issues equity research report on Society Pass Incorporated. (NASDAQ:SOPA) (the "Company"), Southeast Asia's (SEA) next generation e-commerce ecosystem. Click Here for the English version and Click Here for the Chinese version (both on Society Pass website) to view the full Greenridge Global Equity Research Report. Summary Points:• Sapience Investment: Society Pass announced in late-January an $8.8 million investment in Sapience AI, a European-based GPU-as-a-Service provider. With access to Nvidia's Blackwell chips, Sapience is developing smaller sized colocation data centres in Europe that customers can leas

    2/9/26 8:00:00 AM ET
    $SOPA
    Real Estate

    QuinStreet Reports Results for Second Quarter Fiscal 2026

    Record quarterly revenue of $288 million Auto Insurance revenue strong and broadening Continue to expect further margin expansion in 2H FY26 Acquired HomeBuddy in January, significantly expanding Home Services footprint Financial position, balance sheet and cash flow remain strong   QuinStreet, Inc. (NASDAQ:QNST), a leader in performance marketplaces and technologies for the financial services and home services industries, today announced financial results for the fiscal second quarter ended December 31, 2025. For the fiscal second quarter, the Company reported revenue of $287.8 million, up 2% year-over-year. GAAP net income for the fiscal second quarter was $50.2 mill

    2/5/26 4:05:00 PM ET
    $QNST
    Real Estate

    Hub Group Reports Select Preliminary Fourth Quarter and Full Year 2025 Results

    Highlights:  Fourth quarter intermodal volume increased 1% from prior yearStrong year-end balance sheet with cash and restricted cash of approximately $140 million and lower net debt2025 preliminary operating cash flow of approximately $194 million2025 capital expenditures of approximately $45 million  Introduced preliminary 2026 outlook with expected revenue of $3.65 billion to $3.95 billion and capital expenditures of $35 million to $45 million   OAK BROOK, Ill., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Hub Group, Inc. (NASDAQ:HUBG) announced select preliminary fourth quarter and full year 2025 financial results and delayed its earnings release and conference call. The Company also announced

    2/5/26 4:05:00 PM ET
    $HUBG
    Integrated Freight & Logistics
    Industrials

    $ABST
    $ADGI
    $AEG
    $APVO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Kothandaraman Badrinarayanan bought $259,884 worth of shares (5,000 units at $51.98) (SEC Form 4)

    4 - Enphase Energy, Inc. (0001463101) (Issuer)

    2/5/26 4:41:25 PM ET
    $ENPH
    Semiconductors
    Technology

    President and CEO Altman Peter bought $5,650 worth of shares (5,000 units at $1.13), increasing direct ownership by 2% to 273,866 units (SEC Form 4)

    4 - BioCardia, Inc. (0000925741) (Issuer)

    2/4/26 5:47:41 PM ET
    $BCDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    President and CEO Altman Peter bought $1,194 worth of shares (900 units at $1.33), increasing direct ownership by 0.34% to 268,866 units (SEC Form 4)

    4 - BioCardia, Inc. (0000925741) (Issuer)

    1/21/26 5:03:15 PM ET
    $BCDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ABST
    $ADGI
    $AEG
    $APVO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Kothandaraman Badrinarayanan bought $259,884 worth of shares (5,000 units at $51.98) (SEC Form 4)

    4 - Enphase Energy, Inc. (0001463101) (Issuer)

    2/5/26 4:41:25 PM ET
    $ENPH
    Semiconductors
    Technology

    President and CEO Altman Peter bought $5,650 worth of shares (5,000 units at $1.13), increasing direct ownership by 2% to 273,866 units (SEC Form 4)

    4 - BioCardia, Inc. (0000925741) (Issuer)

    2/4/26 5:47:41 PM ET
    $BCDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Wampler Kira Scherer converted options into 2,000 shares and sold $74,660 worth of shares (2,000 units at $37.33) (SEC Form 4)

    4 - Doximity, Inc. (0001516513) (Issuer)

    2/4/26 4:11:16 PM ET
    $DOCS
    EDP Services
    Technology

    $ABST
    $ADGI
    $AEG
    $APVO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Doximity upgraded by Canaccord Genuity with a new price target

    Canaccord Genuity upgraded Doximity from Hold to Buy and set a new price target of $34.00

    2/9/26 6:58:22 AM ET
    $DOCS
    EDP Services
    Technology

    Hub Group downgraded by Stifel with a new price target

    Stifel downgraded Hub Group from Buy to Sell and set a new price target of $27.00

    2/6/26 8:09:27 AM ET
    $HUBG
    Integrated Freight & Logistics
    Industrials

    Hub Group downgraded by Robert W. Baird with a new price target

    Robert W. Baird downgraded Hub Group from Outperform to Neutral and set a new price target of $29.00

    2/6/26 8:09:07 AM ET
    $HUBG
    Integrated Freight & Logistics
    Industrials

    $ABST
    $ADGI
    $AEG
    $APVO
    Financials

    Live finance-specific insights

    View All

    QuinStreet Reports Results for Second Quarter Fiscal 2026

    Record quarterly revenue of $288 million Auto Insurance revenue strong and broadening Continue to expect further margin expansion in 2H FY26 Acquired HomeBuddy in January, significantly expanding Home Services footprint Financial position, balance sheet and cash flow remain strong   QuinStreet, Inc. (NASDAQ:QNST), a leader in performance marketplaces and technologies for the financial services and home services industries, today announced financial results for the fiscal second quarter ended December 31, 2025. For the fiscal second quarter, the Company reported revenue of $287.8 million, up 2% year-over-year. GAAP net income for the fiscal second quarter was $50.2 mill

    2/5/26 4:05:00 PM ET
    $QNST
    Real Estate

    Hub Group Reports Select Preliminary Fourth Quarter and Full Year 2025 Results

    Highlights:  Fourth quarter intermodal volume increased 1% from prior yearStrong year-end balance sheet with cash and restricted cash of approximately $140 million and lower net debt2025 preliminary operating cash flow of approximately $194 million2025 capital expenditures of approximately $45 million  Introduced preliminary 2026 outlook with expected revenue of $3.65 billion to $3.95 billion and capital expenditures of $35 million to $45 million   OAK BROOK, Ill., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Hub Group, Inc. (NASDAQ:HUBG) announced select preliminary fourth quarter and full year 2025 financial results and delayed its earnings release and conference call. The Company also announced

    2/5/26 4:05:00 PM ET
    $HUBG
    Integrated Freight & Logistics
    Industrials

    Powell Industries Announces First Quarter Fiscal 2026 Results

    HOUSTON, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Powell Industries, Inc. (NASDAQ:POWL), a leading supplier of custom-engineered solutions for the management, control and distribution of electrical energy, today announced results for the first quarter Fiscal 2026 ended December 31, 2025. All comparisons are to the first quarter Fiscal 2025, unless otherwise noted. First Quarter Key Highlights:  Revenues of $251 million increased 4%;Gross profit of $71 million, or 28.4% of revenue, increased 20%;Net income of $41 million, or $3.40 per diluted share, increased 19%;New orders(1) totaled $439 million, an increase of 63%;Backlog(2) as of December 31, 2025 totaled $1.6 billion, an increase of 16%;Cas

    2/3/26 4:15:00 PM ET
    $POWL
    Electrical Products
    Energy

    $ABST
    $ADGI
    $AEG
    $APVO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by SES AI Corporation

    SC 13D/A - SES AI Corp (0001819142) (Subject)

    11/19/24 4:15:56 PM ET
    $SES
    Industrial Machinery/Components
    Miscellaneous

    Amendment: SEC Form SC 13D/A filed by Mersana Therapeutics Inc.

    SC 13D/A - Mersana Therapeutics, Inc. (0001442836) (Subject)

    11/15/24 4:45:57 PM ET
    $MRSN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Mersana Therapeutics Inc.

    SC 13G/A - Mersana Therapeutics, Inc. (0001442836) (Subject)

    11/14/24 5:45:55 PM ET
    $MRSN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABST
    $ADGI
    $AEG
    $APVO
    Leadership Updates

    Live Leadership Updates

    View All

    Omnicom Appoints Jantzen Bridges as Global President of its Enterprise Transformation Consultancy

    NEW YORK, Jan. 29, 2026 /PRNewswire/ -- Omnicom (NYSE:OMC), the world's leading marketing and sales company, today announced the appointment of Jantzen Bridges as Global President of Credera, Omnicom's enterprise transformation consultancy. In this role, Bridges will shape service and delivery strategy and partner with enterprise leaders on large-scale, AI-enabled transformation programs. Under Bridges' leadership, Omnicom is significantly expanding its ability to help clients modernize their organizations, optimize the execution of their marketing and sales programs, and drive revenue and customer growth. Omnicom has unmatched creative, commerce, and media capabilities. Credera engages at

    1/29/26 9:30:00 AM ET
    $OMC
    Advertising
    Consumer Discretionary

    Kevin Guest Returns to USANA Health Sciences as CEO

    USANA Health Sciences, Inc. (NYSE:USNA) announced today a leadership transition as part of the Company's ongoing commitment to accelerating growth and enhancing shareholder value. Kevin Guest is returning to lead the Company as Chief Executive Officer, effective immediately. Mr. Guest, who has spent more than three decades at the Company, including eight years as CEO and the last three years as Executive Chairman, has agreed to again serve as USANA's CEO and will continue serving as Chairman. Mr. Guest succeeds Jim Brown, who has stepped down from his position of CEO and President. "We thank Jim for his contributions and his leadership over the past 19 years and in his role as CEO over th

    1/8/26 9:00:00 AM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    Canopy Growth to Acquire MTL Cannabis; Transaction Expected to Create Canada's Leading Medical Cannabis Business and Enhance Capacity to Serve Growing International Demand

    This news release constitutes a "designated news release" for the purposes of Canopy Growth's prospectus supplement dated August 29, 2025 to its short form base shelf prospectus dated June 5, 2024 All financial amounts in this press release are expressed in Canadian dollars. Highly accretive business combination expected to generate significant run-rate synergies of approximately $10 million within 18 months Strengthens Canopy Growth's presence in Québec with an opportunity to expand national distribution of MTL's high-quality, budtender-recommended product portfolio2 MTL's core management team is expected to join Canopy Growth to drive cultivation excellence and enhance the Company's p

    12/15/25 7:00:00 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care